Combination therapy with amantadine and interferon in naı̈ve patients with chronic hepatitis C: meta-analysis of individual patient data from six clinical trials
- 1 March 2004
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 40 (3) , 478-483
- https://doi.org/10.1016/j.jhep.2003.11.002
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Interferon and amantadine in naive chronic hepatitis C: A double-blind, randomized, placebo-controlled trialHepatology, 2002
- Interferon plus amantadine versus interferon alone in the treatment of naı̈ve patients with chronic hepatitis C: a UK multicentre studyJournal of Hepatology, 2001
- Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck?Journal of Hepatology, 2001
- Interferon and amantadine in combination as initial treatment for chronic hepatitis C patientsJournal of Hepatology, 2001
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialPublished by Elsevier ,2001
- A Randomized Trial of Amantadine and Interferon Versus Interferon Alone As Initial Treatment for Chronic Hepatitis CHepatology, 2001
- Randomized, double-blind, placebo-controlled trial of interferon Alfa2a with and without amantadine as initial treatment for chronic hepatitis CHepatology, 2000
- EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999Journal of Hepatology, 1999
- The application of REML in clinical trialsStatistics in Medicine, 1994